Combination of a selective noradrenaline reuptake inhibitor and a PDEV inhibitor

Details for Australian Patent Application No. 2005270904 (hide)

Owner Pfizer Inc.

Inventors Hughes, Bernadette

Agent Allens Arthur Robinson

Pub. Number AU-A-2005270904

PCT Pub. Number WO2006/016262

Priority 60/606,302 31.08.04 US; 0417777.0 10.08.04 GB

Filing date 29 July 2005

Wipo publication date 16 February 2006

International Classifications

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/016262 Priority application(s): WO2006/016262

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270917-Gastrin-specific interfering RNA

2005270900-Implant for treating rotator cuff injuries